Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STABHA vs Dextrose vs Saline for MCL in Knee OA
NCT06620874Not yet recruiting
- Start
- Oct 2024
- Primary completion
- Jun 2025
- Modality
- Biologic
01
Overview
Randomised, double-blind trial of STABHA in knee osteoarthritis (OA) and Medial Collateral Ligament injury (MCL) (3 arms). Primary endpoint: Pain Reduction Using WOMAC Osteoarthritis Index at 3 months. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
STABHA
03
Conditions
knee osteoarthritis (OA)Medial Collateral Ligament injury (MCL)
Beyond the preview
Go deeper on NCT06620874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06620874.